Theragent

Theragent is an advanced therapy contract development and manufacturing organization that focuses on novel cell and gene therapies for the treatment of cancer and rare diseases. The company’s innovative cGMP facility offers comprehensive end-to-end manufacturing and in-house testing capabilities for both clinical and commercial purposes. With a strong emphasis on quality, safety, and manufacturing, Theragent is committed to providing value-added solutions to clients with challenging preclinical and clinical trial programs.